The NAFLD liver fat score (NLFS) was used to evaluate the measurement of liver fat content from 470 patients and suggested that the presence of MetS, an increased fasting serum insulin and plasma glucose, and a decreased aspartate aminotransferase/alanine aminotransferase ratio can be a strong MASH predictor [65]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.